Compare, Analyse Cipla with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs TEVA PHARMA (Israel) - Comparison Results

CIPLA     Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CIPLA   TEVA PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-20
TEVA PHARMA
Dec-13
CIPLA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs5863,060-   
Low Rs3572,659-   
Sales per share (Unadj.) Rs207.01,756.4-  
Earnings per share (Unadj.) Rs18.6109.7-  
Cash flow per share (Unadj.) Rs33.2251.7-  
Dividends per share (Unadj.) Rs4.0096.05-  
Dividend yield (eoy) %0.83.4 25.3%  
Book value per share (Unadj.) Rs195.51,951.0-  
Shares outstanding (eoy) m806.35848.00-   
Bonus / Rights / Conversions ESOS--  
Price / Sales ratio x2.31.6 139.8%   
Avg P/E ratio x25.326.1 97.2%  
P/CF ratio (eoy) x14.211.4 125.0%  
Price / Book Value ratio x2.41.5 164.4%  
Dividend payout %21.587.5 24.6%   
Avg Mkt Cap Rs m379,9122,424,839 15.7%   
No. of employees `00025.844.9 57.5%   
Total wages/salary Rs m30,2700-   
Avg. sales/employee Rs Th6,459.633,138.8 19.5%   
Avg. wages/employee Rs Th1,171.20-   
Avg. net profit/employee Rs Th580.22,070.2 28.0%   
INCOME DATA
Net Sales Rs m166,9491,489,422 11.2%  
Other income Rs m3,4420-   
Total revenues Rs m170,3911,489,422 11.4%   
Gross profit Rs m32,060407,879 7.9%  
Depreciation Rs m11,747120,391 9.8%   
Interest Rs m1,97429,255 6.7%   
Profit before tax Rs m21,782258,233 8.4%   
Minority Interest Rs m-4751,173 -40.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-169,516 0.0%   
Tax Rs m6,312-3,153 -200.2%   
Profit after tax Rs m14,99593,043 16.1%  
Gross profit margin %19.227.4 70.1%  
Effective tax rate %29.0-1.2 -2,373.5%   
Net profit margin %9.06.2 143.8%  
BALANCE SHEET DATA
Current assets Rs m117,0381,005,950 11.6%   
Current liabilities Rs m43,931877,274 5.0%   
Net working cap to sales %43.88.6 506.9%  
Current ratio x2.71.1 232.3%  
Inventory Days Days9691 105.4%  
Debtors Days Days8596 88.7%  
Net fixed assets Rs m107,424486,478 22.1%   
Share capital Rs m1,6133,666 44.0%   
"Free" reserves Rs m156,0180-   
Net worth Rs m157,6301,654,466 9.5%   
Long term debt Rs m23,693761,575 3.1%   
Total assets Rs m236,6263,403,808 7.0%  
Interest coverage x12.09.8 122.5%   
Debt to equity ratio x0.20.5 32.7%  
Sales to assets ratio x0.70.4 161.2%   
Return on assets %7.23.6 199.6%  
Return on equity %9.55.6 169.2%  
Return on capital %12.84.9 260.4%  
Exports to sales %33.00-   
Imports to sales %00-   
Net fx Rs m49,2720-   
CASH FLOW
From Operations Rs m30,685237,337 12.9%  
From Investments Rs m1,040-84,098 -1.2%  
From Financial Activity Rs m-29,488-284,702 10.4%  
Net Cashflow Rs m2,340-131,463 -1.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 73.32 Rs / USD

Compare CIPLA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare CIPLA With: PFIZER  ABBOTT INDIA  FDC  NATCO PHARMA  SUN PHARMA  



Today's Market

5 Reasons Why Sensex Zoomed 613 Points Today(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note.

Related Views On News

Cipla's Q4 Update: Net Profit Surges 68%; Company to Pay Rs 5 Dividend (Views On News)

May 17, 2021

Here's a rundown on the latest quarterly results of Cipla.

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Gland Pharma Q4 results: Net profit rises 34%; Share Price Hits New 52-Week High (Views On News)

May 18, 2021

The new vaccine business is expected to accelerate the company's long-term strategy of entering into the biosimilar space.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Revealing at 5pm Today: The Great Indian Wealth Project
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CIPLA SHARE PRICE


May 18, 2021 (Close)

TRACK CIPLA

MORE ON CIPLA

CIPLA 8-QTR ANALYSIS

COMPARE CIPLA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS